Usage: MOUNJARO® is indicated to improve glycemic control in adults with type 2 diabetes mellitus, and is to be used alongside diet and exercise.
zepbound
(tirzepatide)
Eli Lilly and Company
Usage: ZEPBOUND® is indicated for adults with obesity or overweight (with at least one weight-related comorbidity) to aid in weight reduction and maintenance, and to treat moderate to severe obstructive sleep apnea in the context of obesity. Coadministration with other tirzepatide or GLP-1 receptor agonists is not recommended.